- Type / Class
- Equity / Common Stock
- Shares outstanding
- 152,309,909
- Total 13F shares
- 158,850,861
- Share change
- +409,638
- Total reported value
- $8,835,899,945
- Put/Call ratio
- 67%
- Price per share
- $55.63
- Number of holders
- 569
- Value change
- +$43,569,058
- Number of buys
- 304
- Number of sells
- 252
Quarterly Holders Quick Answers
What is CUSIP 09073M104?
CUSIP 09073M104 identifies TECH - BIO-TECHNE Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09073M104:
Top shareholders of TECH - BIO-TECHNE Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
12%
|
18,438,322
|
$948,651,667 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7%
from 13D/G
|
12,171,216
|
$626,209,085 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
13D/G
|
Company · T. Rowe Price Associates, Inc. |
2.2%
from 13D/G
|
8,847,931
|
$455,227,000 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
4.3%
|
6,578,943
|
$338,486,750 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.8%
|
5,858,583
|
$301,424,095 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.7%
|
4,062,509
|
$208,615,505 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
2.4%
|
3,662,725
|
$188,447,201 | — | 30 Jun 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
2.3%
|
3,436,966
|
$176,831,943 | — | 30 Jun 2025 | |
| Select Equity Group, L.P. |
13F
|
Company |
1.9%
|
2,919,495
|
$150,208,018 | — | 30 Jun 2025 | |
| BAMCO INC /NY/ |
13F
|
Company |
1.8%
|
2,795,147
|
$143,810,313 | — | 30 Jun 2025 | |
| DF DENT & CO INC |
13F
|
Company |
1.8%
|
2,724,742
|
$140,187,977 | — | 30 Jun 2025 | |
| MAIRS & POWER INC |
13F
|
Company |
1.8%
|
2,716,378
|
$139,757,638 | — | 30 Jun 2025 | |
| Champlain Investment Partners, LLC |
13F
|
Company |
1.8%
|
2,665,684
|
$137,149,442 | — | 30 Jun 2025 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
1.7%
|
2,619,101
|
$134,752,746 | — | 30 Jun 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
1.6%
|
2,499,969
|
$128,623,419 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.6%
|
2,470,862
|
$127,125,850 | — | 30 Jun 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1.5%
|
2,349,712
|
$120,892,682 | — | 30 Jun 2025 | |
| RGM Capital, LLC |
13F
|
Company |
1.4%
|
2,200,052
|
$113,192,675 | — | 30 Jun 2025 | |
| Charles R. Kummeth |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
1,938,164
mixed-class rows
|
$103,771,891 | — | 15 Aug 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.3%
|
1,923,092
|
$98,943,084 | — | 30 Jun 2025 | |
| NORGES BANK |
13F
|
Company |
1.3%
|
1,909,395
|
$98,238,373 | — | 30 Jun 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.2%
|
1,797,586
|
$92,485,533 | — | 30 Jun 2025 | |
| BROWN ADVISORY INC |
13F
|
Company |
1.2%
|
1,775,361
|
$91,342,285 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
1,666,237
|
$85,727,871 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.1%
|
1,661,341
|
$85,481,083 | — | 30 Jun 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.1%
|
1,655,938
|
$85,198,009 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,640,649
|
$84,411,391 | — | 30 Jun 2025 | |
| BROWN CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
1,573,603
|
$80,961,874 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1%
|
1,552,440
|
$79,873,038 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.94%
|
1,425,518
|
$73,342,902 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.89%
|
1,358,823
|
$69,911,480 | — | 30 Jun 2025 | |
| SNYDER CAPITAL MANAGEMENT L P |
13F
|
Company |
0.88%
|
1,334,441
|
$68,656,989 | — | 30 Jun 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
0.81%
|
1,238,095
|
$63,700,000 | — | 30 Jun 2025 | |
| GENEVA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.78%
|
1,185,099
|
$60,973,359 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.75%
|
1,142,819
|
$58,798,037 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.75%
|
1,137,107
|
$58,504,154 | — | 30 Jun 2025 | |
| Aristotle Atlantic Partners, LLC |
13F
|
Company |
0.69%
|
1,052,277
|
$54,139,640 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.67%
|
1,023,920
|
$52,680,702 | — | 30 Jun 2025 | |
| Capital Research Global Investors |
13F
|
Company |
0.66%
|
1,005,950
|
$51,756,128 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.65%
|
992,386
|
$51,058,259 | — | 30 Jun 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.64%
|
972,085
|
$50,013,773 | — | 30 Jun 2025 | |
| RIVERBRIDGE PARTNERS LLC |
13F
|
Company |
0.63%
|
954,889
|
$49,129,046 | — | 30 Jun 2025 | |
| AMERICAN CAPITAL MANAGEMENT INC |
13F
|
Company |
0.62%
|
951,614
|
$48,960,540 | — | 30 Jun 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.57%
|
870,887
|
$44,807,136 | — | 30 Jun 2025 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
0.56%
|
845,523
|
$43,502,158 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.54%
|
818,138
|
$42,093,200 | — | 30 Jun 2025 | |
| WEITZ INVESTMENT MANAGEMENT, INC. |
13F
|
Company |
0.53%
|
802,150
|
$41,270,618 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.52%
|
787,624
|
$40,523,272 | — | 30 Jun 2025 | |
| Ownership Capital B.V. |
13F
|
Company |
0.47%
|
721,840
|
$37,138,668 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.47%
|
717,591
|
$36,920,058 | — | 30 Jun 2025 |
Institutional Holders of BIO-TECHNE Corp - Common Stock (TECH) as of Q3 2025
As of 30 Sep 2025,
BIO-TECHNE Corp - Common Stock (TECH) was held by
569 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
158,850,861 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., MORGAN STANLEY, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, Invesco Ltd., PRICE T ROWE ASSOCIATES INC /MD/, NEUBERGER BERMAN GROUP LLC, and MAVERICK CAPITAL LTD.
This page lists
570
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
549
Q3 2025 holders
569
Holder diff
20
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.